000			02119 a2200649 4500
005			20250513202105.0
264		0	_c20000229
008			200002s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.2000.18.3.659 _2doi
040			_aNLM _beng _cNLM
100	1		_aTakimoto, C H
245	0	0	_aPhase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cFeb 2000
300			_a659-67 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents, Phytogenic _xadministration & dosage
650	0	4	_aCamptothecin _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHematologic Diseases _xchemically induced
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aIrinotecan
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNausea _xchemically induced
650	0	4	_aNeoplasms _xblood
650	0	4	_aVomiting _xchemically induced
700	1		_aMorrison, G
700	1		_aHarold, N
700	1		_aQuinn, M
700	1		_aMonahan, B P
700	1		_aBand, R A
700	1		_aCottrell, J
700	1		_aGuemei, A
700	1		_aLlorens, V
700	1		_aHehman, H
700	1		_aIsmail, A S
700	1		_aFlemming, D
700	1		_aGosky, D M
700	1		_aHirota, H
700	1		_aBerger, S J
700	1		_aBerger, N A
700	1		_aChen, A P
700	1		_aShapiro, J D
700	1		_aArbuck, S G
700	1		_aWright, J
700	1		_aHamilton, J M
700	1		_aAllegra, C J
700	1		_aGrem, J L
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 18 _gno. 3 _gp. 659-67
856	4	0	_uhttps://doi.org/10.1200/JCO.2000.18.3.659 _zAvailable from publisher's website
999			_c10608913 _d10608913